Yervoy 200 mg/40 mL injection Images
Generic Name: ipilimumab
This medication has been identified as Yervoy 200 mg/40 mL injection. It is supplied by Bristol-Myers Squibb Company.
Yervoy is used in the treatment of Melanoma, Metastatic; Colorectal Cancer; Malignant Pleural Mesothelioma; Melanoma; Renal Cell Carcinoma and belongs to the drug class anti-CTLA-4 monoclonal antibodies. Risk cannot be ruled out during pregnancy. Yervoy 200 mg/40 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Yervoy
- Generic Name
- ipilimumab
- Strength
- 200 mg/40 mL injection
- Availability
- Prescription only
- Drug Class
- Anti-CTLA-4 monoclonal antibodies
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb Company
- National Drug Code (NDC)
- 00003-2328
See also:
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Lumakras
Lumakras is used to treat KRAS G12C-mutated non-small cell lung cancer (NSCLC) or colorectal cancer ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Lenvima
Lenvima (lenvatinib) is used to treat thyroid cancer, advanced renal cell carcinoma, hepatocellular ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
More about Yervoy (ipilimumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-CTLA-4 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.